PHIO PHARMACEUTICALS CORP. Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31)
PHIO PHARMACEUTICALS CORP. (PHIO) reported Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) of 100 shares for the 1-month period ending 2011-09-08, per its 10-Q filed 2013-08-14.
Discontinued › Notes
us-gaap:StockIssuedDuringPeriodSharesIssuedForCash · last filed 2013-08-14
- 2011-09-08: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 100.00 shares.
| Period end | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month |
|---|---|
| 2011-09-08 | 100.00 shares 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |